DCM Shriram Fine Chemicals accepts resignation of independent director Behara

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Venkata Rama Subbu Behara resigned as independent director effective September 8, 2026
  • Departure attributed to recent changes in the board structure
  • Resignation filed under Regulation 30 of SEBI LODR Regulations, 2015
  • Behara retains directorships at MTAR Technologies and Gabriel India
powered bylight_fuzz_icon
50487399

*this image is generated using AI for illustrative purposes only.

DCM Shriram Fine Chemicals accepted the resignation of Venkata Rama Subbu Behara as an independent director effective September 8, 2026. The departure follows recent changes in the company’s board structure.

The resignation was formalized through a letter dated September 8, 2026, submitted to Ms. Urvashi Tilak Dhar. Behara confirmed there are no other material reasons for his exit beyond the structural adjustments mentioned in his resignation letter.

Regulatory Compliance

The company disclosed the change pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing also referenced SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Kokila Arora, Company Secretary and Compliance Officer, signed the intimation filed with both the BSE and NSE on September 9, 2026.

Director Profile

Behara continues to hold directorships in other listed entities. His current roles include:

  • MTAR Technologies Limited: Member of the Audit Committee, Chairman of the Stakeholders' Relationship Committee, Member of the Nomination and Remuneration Committee, and Chairman of the Risk Management Committee.
  • Gabriel India Limited: Member of the Stakeholders' Relationship Committee and the Nomination and Remuneration Committee.

Historical Stock Returns for DCM Shriram Fine Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-1.31%+1.23%+5.18%-9.16%0.0%0.0%

Who has been nominated as the replacement independent director for Venkata Rama Subbu Behara, and when is their appointment expected to be finalized?

How might this board restructuring impact DCM Shriram Fine Chemicals' strategic decision-making and governance oversight in the near term?

Given Behara's extensive committee roles at MTAR Technologies, will his departure from DCM Shriram affect his capacity to serve on those boards?

DCM Shriram Fine Chemicals
View Company Insights
View All News
like19
dislike

DCM Shriram Fine Chemicals appoints Anil Kumar Khaitan as independent director

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Anil Kumar Khaitan appointed as non-executive independent director
  • Five-year term effective September 4, 2026, subject to shareholder approval
  • Brings 48 years of experience across pharma, steel, and jute sectors
  • Appointment approved by Board on September 3, 2026
powered bylight_fuzz_icon
49978828

*this image is generated using AI for illustrative purposes only.

DCM Shriram Fine Chemicals Ltd has appointed Anil Kumar Khaitan as an additional non-executive independent director. The appointment is effective September 4, 2026, and is subject to shareholder approval.

The Board of Directors approved the induction during its meeting held on September 3, 2026. The decision was made pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

Appointment Details

Mr. Khaitan will serve a term of five consecutive years, from September 4, 2026, to September 3, 2031. The Nomination and Remuneration Committee recommended his appointment to the Board.

Particulars Details
Name Anil Kumar Khaitan
DIN 00759951
Category Non-Executive Independent Director
Term Start September 4, 2026
Term End September 3, 2031

Profile and Experience

Mr. Khaitan, aged 70, is the Chairman of SNK Corp. He holds a B.Com degree and an MBA from IMI, Geneva (1981). He joined his family business in 1976.

He brings 48 years of diversified business experience across the jute, paper, pharmaceutical, copper, and steel industries, including international operations. His expertise includes strategic business planning, financial management, and human resource development.

Mr. Khaitan is a past President of PHD CCI and has served on the executive committees of FICCI and ASSOCHAM. He is also Chairman of the Governing Board of the ICSI Registered Valuers Organization.

Regulatory Compliance

The company confirmed that none of the existing directors are related to Mr. Khaitan. He is not debarred from holding office under any SEBI order or authority directive.

Historical Stock Returns for DCM Shriram Fine Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-1.31%+1.23%+5.18%-9.16%0.0%0.0%

How might Mr. Khaitan's extensive experience in pharmaceuticals and steel influence DCM Shriram's strategic diversification or supply chain resilience?

What specific governance reforms or board committee assignments are anticipated for Mr. Khaitan given his background in valuation and industry leadership?

Could this appointment signal an upcoming shift in DCM Shriram's capital allocation strategy or M&A activities under new board oversight?

DCM Shriram Fine Chemicals
View Company Insights
View All News
like15
dislike

More News on DCM Shriram Fine Chemicals

1 Year Returns:0.00%